"Biomedical Research Journal (BRJ)" is a premier peer reviewed open access journal, published by Sunandan Divatia School of Science, NMIMS (Deemed-to-be) University, Mumbai, for promoting interdisciplinary contemporary areas of Basic and Applied Biomedical Science. The goal is to share new discoveries and translational knowledge with scientists, academicians, clinicians and students in the field of Biomedical and Biological/Chemical/ Biotechnology/Stem Cell Biology/Cancer Biology in the realm of basic and applied aspects in the different areas.
BRJ aims at creating a platform to help advance the domains and frontiers of inter- and multi-disciplinary research across the various areas of sciences and recent advances in cross pollination across Biology, Chemistry, Medicine, Physics and Mathematics. Integrative science is the present and future of science, and the various aspects of the journal proposes to highlight and emphasize contemporary technology towards understanding various aspects of the sciences.
The focus areas of BRJ include review articles and original research papers in Cancer biology, Stem cell biology, Nanoscience and Pharmaceutical Science. A rigorous peer review process is implemented to judge the effectiveness, legitimacy and reliability of the research content. The journal is published biannually online as well as print copies.
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet, Wanfang Data
The journal is indexed with, or included in, the following:
Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp
Open Access Publication and Creative Commons Licensing
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.
Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.
CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.
Ahead of Print policy
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
- "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
- The Editorial Board has full and final approval over the content of all advertisements.
- Advertisers will never be shown any manuscripts or other content prior to publication.